On Invalid Date, Novo Nordisk A S (NYSE: NVO) reported Q3 2022 earnings per share (EPS) of $0.83, up 0.24% year over year. Total Novo Nordisk A S earnings for the quarter were $1.87 billion. In the same quarter last year, Novo Nordisk A S's earnings per share (EPS) was $0.83.
As of Q1 2023, Novo Nordisk A S's earnings has grown -3.8% year over year. This is 20.04 percentage points lower than the US Biotechnology industry earnings growth rate of 16.24%. Novo Nordisk A S's earnings in the past year totalled $6.99 billion.
What is NVO's earnings date?
Novo Nordisk A S's earnings date is Invalid Date. Add NVO to your watchlist to be reminded of NVO's next earnings announcement.
What was NVO's revenue last quarter?
On Invalid Date, Novo Nordisk A S (NYSE: NVO) reported Q3 2022 revenue of $5.90 billion up 6.04% year over year. In the same quarter last year, Novo Nordisk A S's revenue was $5.57 billion.
What was NVO's revenue growth in the past year?
As of Q1 2023, Novo Nordisk A S's revenue has grown 2.97% year over year. This is 114.01 percentage points lower than the US Biotechnology industry revenue growth rate of 116.99%. Novo Nordisk A S's revenue in the past year totalled $22.12 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.